UK Rejects Blood Glucose Health Claim For White Mulberry Supplement
The UK Nutrition and Health Claims Committee has rejected the health claim “clinically proven in assisting healthy blood glucose levels” in the target population of type 2 diabetics for Ascarit’s white mulberry-based dietary supplement.
You may also be interested in...
Ascarit is seeking UK approval for the health claim “clinically proven in assisting healthy blood glucose levels” in the target population of type 2 diabetics for its white mulberry-based dietary supplement. It will be just the second claim assessed by the UK Nutrition and Health Claims Committee which took over the role from EFSA on 1 January 2021 following Brexit.
A round-up of the latest appointments in Europe's health and wellness sector: Mayoly Spindler names leadership team following acquisition of Ipsen Consumer Healthcare; Sanofi unveils new Consumer Healthcare head for France; and ex-HRA Pharma CEO David Wright joins Ceuta Group.
Cases of acute tubulointerstitial nephritis linked to omeprazole use flagged to the EMA leads to new product information warnings related to a possible risk of kidney inflammation for drugs containing the PPI sold in the EU.